|
HS Code |
779862 |
As an accredited 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry shapes the world, often in subtle ways. One compound that's caught the attention of research communities is 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One. This isn’t just a line of chemical code on a storage bottle — it represents years of incremental discovery and practical observation. Laboratories need compounds like this for day-to-day work in medicinal chemistry, agricultural chemistry, and detailed bioassays. Taking a fresh look at it reveals more than just molecular weights or formulas on a label.
You won’t find this compound on a drugstore shelf, but its presence threads through many routes of drug design and synthesis. At its core, the molecule blends a bromine atom with the oxazolo-pyridone framework — a structure that hooks scientists looking for new building blocks in heterocyclic chemistry. A specific position for bromine gives it unique reactivity, opening paths some other pyridin-2-one derivatives simply can’t provide.
What stands out in my own time as a lab assistant years ago is how chemists reach for these precise heterocycles when each step in a synthetic route demands clarity and confidence. A slight tweak, such as the substitution of bromine, offers new launching points for further reactions. Here, the significance is direct: synthesis routes that might stall with generic materials move forward with purpose-built compounds like this.
Looking at the practical details, 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One generally arrives as a finely powdered solid, a tangible marker of the precision behind its preparation. The molecular weight falls in the typical range for medium-sized heterocyclic scaffolds, sitting comfortably for weighing, dissolving, or further modification. Stability under standard room conditions means storage and transport don’t require complicated precautions; still, dry and cool environments offer the best shelf life for most lab-grade solids.
I’ve found folks appreciate transparency about purity, so labs often provide compounds like this at 95% purity or above. Minute differences matter when you’re tracing byproducts during synthesis or evaluation. Even a half-percent impurity has confused a chromatogram for us more than once, so reliable providers carry weight here.
Colleagues in drug discovery appreciate the specific shape and electronic properties of 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One. A bromine atom, compared to hydrogen or chlorine, adds a useful handle for Suzuki couplings, Buchwald–Hartwig aminations, or even SNAr substitutions. In practice, this opens doors for building up or swapping out large portions of a molecule late in a synthetic sequence.
Heterocycles like this show up repeatedly as “privileged structures” in medicinal chemistry literature. Privileged not just in theory, but in experience: we often see these motifs pop up in inhibitors targeting kinases, or as scaffolds for anti-infective leads. The unique electronic arrangement created by the oxazolo-pyridinone system creates a binding surface that interacts tightly with biological targets. That puts 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One right in the center for those aiming to build focused libraries for screening or structure–activity relationship studies.
For those in agrochemicals, the same properties drive activity against fungal or bacterial pests in crops. Biology doesn’t care about categories; what works for labs can often translate to the field. Through personal observation, I’ve seen colleagues use compounds like this to quickly assemble analogs for early toxicity and efficacy screens, saving precious months during a season’s development window.
Walking into a shared lab after another team has been at the bench, I’ve learned the hard way that imprecise reagents slow down every step. Purity offers more than peace of mind. Results snap into focus with clean starting materials. With a compound like 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One, even a slight variation in isomer distribution or residual solvent can upset a well-laid synthesis and force time-consuming troubleshooting. Results speak clearly: dependable synthesis needs dependable inputs.
Consistency from batch to batch matters, especially in industrial settings where scaling up from milligrams to kilograms stretches processes to the limit. Keeping tabs on melting point, NMR spectra, and even the color or slight odor — these all offer clues about what’s really in the bottle. Trust builds not just from numbers printed on a data sheet, but from experience matching observed reality to expectations every single time.
Not every pyridin-2-one is created equal. Swapping out the bromine at position six transforms both chemical behavior and downstream application. In undergraduate labs, a hydrogen at this spot might suffice for easy substitutions, but move into more intricate medicinal chemistry, and bromine opens up the world of cross-coupling, offering higher yields and cleaner selectivity. Chlorinated analogs sometimes fall short in both reactivity and solubility — a bromine atom strikes a middle ground, offering enough bulk to direct reactions, without overwhelming steric hindrance.
My own time comparing related analogs taught me that subtle changes have outsize impacts. Across a dozen analogs, simple swaps in halogen type affected everything from solubility to biological binding. Research articles and patent filings reinforce what we see at the bench: 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One presents a set of properties not matched by other, seemingly minor, variants. That uniqueness fuels its inclusion in focused libraries and pilot studies — labs want to compare performance across a true family of analogs, not just a handful that look similar on paper.
Science rarely moves in a straight line, and practical experience often brings the lessons that textbooks miss. One group working on kinase inhibitors found that shifting from a 6-chloro to 6-bromo analog pushed selectivity much higher, unlocking interactions deep in the protein’s pocket. Another team, working in a crop science setting, saw fungicidal activity climb when the brominated building block formed part of a more complex active ingredient.
My conversations with both industry and academic chemists reinforce that synthetic convenience matters just as much as performance at the end of the testing cycle. With 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One, the ability to use standard palladium-catalyzed couplings gives research teams options to modify molecules quickly and efficiently, testing more ideas on a tight timeline.
Chemists value compounds that handle predictably. 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One keeps well sealed, weighs out neatly on the balance, and dissolves with a minimum of fuss in most polar organic solvents. Even in busy spaces, like shared academic labs or startup incubators, its stability gives teams the confidence to plan without much risk from rapid degradation or unwanted reactivity.
Of course, standard precautions always apply. Good ventilation, gloves, and goggles matter far more than the particulars of any one compound. Having seen mishaps caused by inattention, I know firsthand how much of lab safety comes from good habits rather than the hazard label alone. 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One offers low volatility and manageable toxicity, yet nobody in their right mind lets habits slip — safety is about process, not just product.
If there’s one major headache facing research projects, it’s the delay between an inspired synthetic idea and getting the right reagents. Stockouts, purity fluctuations, and shifting suppliers can all derail timelines. During an oncology-focused collaborative project I supported, the search for brominated scaffolds involved weeks lost to order backlogs and documentation checks. This is not just about patience; reproducibility depends on unbroken supply chains and trust in what arrives at the bench.
Quality controls, both upstream at the producer and downstream in the lab, play crucial roles. Tight documentation about synthetic routes, batch purity, and residue contents prevents confusion and interruption. More than once, projects hobbled forward on makeshift substitutions that, while not ideal, offered a stopgap while the sought-after compound wound its way through customs or production bottlenecks.
Moving towards more open data sharing and transparent supply networks improves research — not just in keeping timelines but in confidence about what each experiment truly tests. My experience supports the push for suppliers to publish authenticated batch data routinely. This raises the floor for everyone, ensuring good science flows from every bottle or vial.
6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One matters because research isn’t about the flash of inspiration alone. Results build on the quiet dependability of small things: pure building blocks, well-managed stocks, and straightforward scaling from bench to pilot batches. Each property — from chemical reactivity to long-term shelf stability — matters in practice. In the context of global research, where teams span universities, startups, and large companies, a single missing or off-specification compound can kneecap months of work.
What separates products like this from less-selective stock chemicals is the direct fit with current synthetic approaches. Fewer side reactions and less fiddling with reaction conditions get actual results on the board faster. Over time, that trust accumulates as research teams see their data holds up across repeats, scale-ups, and published reports.
Skeptics of chemical specialization sometimes claim there’s too much focus on obscure variants. Direct lab work, though, tells another story. Screening broader structure–activity libraries, hitting new targets, or unlocking easier routes to critical active ingredients all demand precisely these sorts of ‘uncommon’ reagents. I’ve watched projects jump ahead after a single shift in available building blocks, cutting weeks from research timelines and unlocking insights that would otherwise stall out. In some cases, student projects led to patents — all enabled by access to carefully curated, trusted compounds.
Real innovation builds on the foundation provided by compounds like 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One. That’s not about the headline molecules in a new drug or crop protection launch; it’s the hundreds, sometimes thousands, of pieces that come together in modular design and exploration. Each new analog built from this starting point carries the chance to become the next breakthrough, or at least to tell a story about what works — and what doesn’t.
Getting the most out of compounds like 6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One comes down to a few practical steps. Standardized, open reporting on each batch makes it easier for research teams to make critical decisions. Investment in supplier relationships — building on more than just lowest cost — secures continuity, which is worth more than a few saved dollars. Laboratories can push for collaborative networks that consolidate demand and offer advance visibility into supply bottlenecks.
On the technical side, supporting better, greener methods for synthesizing heterocyclic building blocks improves sustainability. These are not just empty buzzwords. Newer catalytic routes reduce waste and speed throughput, cutting costs across academic and industrial settings. My own experience with flow chemistry and safer reagents points to a future where adopting emerging methods brings a double benefit: more consistent output and real-world reductions in hazardous byproducts.
6-Bromo-3H-Oxazolo[4,5-B]Pyridin-2-One stands apart for its utility in forging ahead with new science. Its specific combination of chemical reactivity and predictable handling solves a basket of problems synthetic chemists face daily. Where other heterocycles miss the mark — in reactivity, purity, or scalability — this one delivers for teams chasing the next wave of medicines or crop innovations.
Stepping back, a single compound can’t guarantee success, but it can unlock crucial experiments and bring elusive results into reach. In a crowded field, the ability to rely on every bottle and batch creates a small yet invaluable edge. Drawing on personal and professional experience alike, I’ve seen that edge translate into confidence, shorter timelines, and, ultimately, progress measured both in data and in the new products that reach the world beyond the lab bench.